Literature DB >> 11595606

Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model.

C Zugck1, C Krüger, R Kell, S Körber, D Schellberg, W Kübler, M Haass.   

Abstract

AIMS: The performance of a US-American scoring system (Heart Failure Survival Score, HFSS) was prospectively evaluated in a sample of ambulatory patients with congestive heart failure (CHF). Additionally, it was investigated whether the HFSS might be simplified by assessment of the distance ambulated during a 6-min walk test (6'WT) instead of determination of peak oxygen uptake (peak VO(2)). METHODS AND
RESULTS: In 208 middle-aged CHF patients (age 54+/-10 years, 82% male, NYHA class 2.3+/-0.7; follow-up 28+/-14 months) the seven variables of the HFSS: CHF aetiology; heart rate; mean arterial pressure; serum sodium concentration; intraventricular conduction time; left ventricular ejection fraction (LVEF); and peak VO(2), were determined. Additionally, a 6'WT was performed. The HFSS allowed discrimination between patients at low, medium and high risk, with mortality rates of 16, 39 and 50%, respectively. However, the prognostic power of the HFSS was not superior to a two-variable model consisting only of LVEF and peak VO(2). The areas under the receiver operating curves (AUC) for prediction of 1-year survival were even higher for the two-variable model (0.84 vs. 0.74, P<0.05). Replacing peak VO(2) with 6'WT resulted in a similar AUC (0.83).
CONCLUSION: The HFSS continued to predict survival when applied to this patient sample. However, the HFSS was inferior to a two-variable model containing only LVEF and either peak VO(2) or 6'WT. As the 6'WT requires no sophisticated equipment, a simplified two-variable model containing only LVEF and 6'WT may be more widely applicable, and is therefore recommended.

Entities:  

Mesh:

Year:  2001        PMID: 11595606     DOI: 10.1016/s1388-9842(01)00167-2

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  17 in total

1.  Estimating prognosis in heart failure: time for a better approach.

Authors:  M R Cowie
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

2.  Identifying important risk factors for survival in patient with systolic heart failure using random survival forests.

Authors:  Eileen Hsich; Eiran Z Gorodeski; Eugene H Blackstone; Hemant Ishwaran; Michael S Lauer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-11-23

3.  An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?

Authors:  Barbara S Doumouras; Douglas S Lee; Wayne C Levy; Ana C Alba
Journal:  Curr Heart Fail Rep       Date:  2018-02

4.  Physical and psychological symptom profiling and event-free survival in adults with moderate to advanced heart failure.

Authors:  Christopher S Lee; Jill M Gelow; Quin E Denfeld; James O Mudd; Donna Burgess; Jennifer K Green; Shirin O Hiatt; Corrine Y Jurgens
Journal:  J Cardiovasc Nurs       Date:  2014-07       Impact factor: 2.083

5.  Validation of a cardiopulmonary exercise test score in heart failure.

Authors:  Jonathan Myers; Ricardo Oliveira; Frederick Dewey; Ross Arena; Marco Guazzi; Paul Chase; Daniel Bensimhon; Mary Ann Peberdy; Euan Ashley; Erin West; Lawrence P Cahalin; Daniel E Forman
Journal:  Circ Heart Fail       Date:  2013-02-07       Impact factor: 8.790

6.  Symptom-Hemodynamic Mismatch and Heart Failure Event Risk.

Authors:  Christopher S Lee; Shirin O Hiatt; Quin E Denfeld; James O Mudd; Christopher Chien; Jill M Gelow
Journal:  J Cardiovasc Nurs       Date:  2015 Sep-Oct       Impact factor: 2.083

7.  Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study.

Authors:  David J Whellan; Anil Nigam; Malcolm Arnold; Aijing Z Starr; James Hill; Gerald Fletcher; Stephen J Ellis; Lawton Cooper; Anekwe Onwuanyi; Bleakley Chandler; Steven J Keteyian; Greg Ewald; Andrew Kao; Mihai Gheorghiade
Journal:  Am Heart J       Date:  2011-12       Impact factor: 4.749

8.  Gene polymorphisms and thyroid function in patients with heart failure.

Authors:  Ioannis Vasiliadis; Genovefa Kolovou; Vana Kolovou; Vasiliki Giannakopoulou; Maria Boutsikou; Niki Katsiki; Evaggelia Papadopoulou; Sophie Mavrogeni; Konstantina Sorontila; Costas Pantos; Dennis V Cokkinos
Journal:  Endocrine       Date:  2013-03-30       Impact factor: 3.633

Review 9.  End-of-life options for patients with advanced heart failure.

Authors:  Judith Z Goldfinger; Eric D Adler
Journal:  Curr Heart Fail Rep       Date:  2010-09

10.  Predicting mortality in patients with heart failure: a pragmatic approach.

Authors:  M L Bouvy; E R Heerdink; H G M Leufkens; A W Hoes
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.